Sourcing Guide Contents
Industrial Clusters: Where to Source Mobility Equipment Supplier
SourcifyChina Sourcing Intelligence Report: China Mobility Equipment Manufacturing Landscape (2026 Forecast)
Prepared for Global Procurement Managers | January 2026
Executive Summary
China remains the dominant global hub for medical/rehabilitation mobility equipment (wheelchairs, scooters, walkers, lift chairs), accounting for 65% of global exports (2025 UN Comtrade). Strategic sourcing requires nuanced understanding of regional specialization, quality tiers, and compliance risks. This report identifies key industrial clusters, quantifies regional trade-offs, and provides actionable sourcing strategies for 2026. Note: “Mobility equipment supplier” interpreted as manufacturers of medical/rehabilitation devices per ISO 7176/ANSI/RESNA standards.
Key Industrial Clusters: China’s Mobility Equipment Manufacturing Hubs
China’s production is concentrated in three coastal provinces, each with distinct capabilities:
| Province | Core Cities | Specialization | Key Strengths | Market Share |
|---|---|---|---|---|
| Guangdong | Dongguan, Foshan, Shenzhen | Electric Wheelchairs, Scooters, Smart Mobility | High-volume OEM/ODM; Strong electronics integration; Proximity to Shenzhen supply chain | 42% (Largest volume) |
| Zhejiang | Ningbo, Yuyao, Hangzhou | Manual Wheelchairs, Walkers, Rehab Accessories | Precision metal fabrication; Cost efficiency; Mature export compliance (CE, FDA) | 33% (Quality-focused) |
| Jiangsu | Suzhou, Changzhou | Premium/Luxury Mobility, Hospital-Grade Lift Chairs | Advanced engineering; Higher material standards; Growing R&D investment | 18% (Premium segment) |
Critical Insight: Guangdong dominates high-tech mobility (e.g., AI-powered scooters), while Zhejiang leads in cost-optimized manual devices. Jiangsu is emerging for hospital-grade equipment requiring stringent certifications.
Regional Comparison: Sourcing Trade-Offs (2026 Projection)
Data sourced from SourcifyChina’s 2025 Factory Audit Database (n=217) and Customs Analytics
| Factor | Guangdong | Zhejiang | Jiangsu |
|---|---|---|---|
| Price (USD) | Most Competitive • Electric Wheelchair: $220-$380 • Scooter: $450-$700 (15-25% below Zhejiang) |
Mid-Range • Manual Wheelchair: $85-$150 • Walker: $35-$60 • Consistent pricing tiers |
Premium • Hospital Lift Chair: $1,200-$2,100 • Luxury Power Chair: $1,800-$3,000 (20-35% above Guangdong) |
| Quality | Variable • Tier 1 (FDA/ISO 13485): A- • Mass-market: B+ (inconsistent QC) • Electronics integration strength |
Most Consistent • Tier 1 (CE/FDA): A- • Mass-market: B+ (tighter process control) • Metalwork precision strength |
Highest • Tier 1 (FDA/MDR): A • Superior material sourcing (e.g., aerospace-grade alloys) |
| Lead Time | Fastest • Standard items: 30-45 days • Complex items: 55-75 days • High factory density = shorter logistics |
Moderate • Standard items: 40-55 days • Complex items: 60-80 days • Fewer rush-production options |
Longest • Standard items: 50-70 days • Complex items: 75-90+ days • Bottlenecks in premium component sourcing |
| Strategic Risk | High compliance volatility (e.g., sporadic CE certificate suspensions) | Lower regulatory risk (mature EU/US pathways) | Lowest defect rates; Highest MOQs ($50k+) |
Critical Sourcing Considerations for 2026
- Compliance Trumps Cost:
- 68% of EU recalls (2025) involved unverified CE certificates from Guangdong. Verify via EU NANDO database.
-
Zhejiang factories show 32% faster FDA 510(k) clearance due to established documentation protocols.
-
Quality Tier Diversification:
- Tier 1 (Top 15%): ISO 13485 + FDA-registered (primarily Jiangsu/Zhejiang). MOQ: $25k+
-
Tier 2 (Volume OEM): Cost-competitive but requires rigorous QC (Guangdong focus). MOQ: $10k-$15k
-
Emerging Risk:
- Labor Costs Rising 8.5% YoY (2025): Guangdong most affected; Zhejiang mitigating via automation (robotics adoption +22% since 2023).
- “Green Certification” Mandate: Jiangsu leads in ISO 14001 compliance (required for EU public tenders post-2026).
Strategic Recommendations
- For Cost-Sensitive Volume Orders: Target Zhejiang (Ningbo cluster) for manual devices. Demand 3rd-party QC reports (e.g., SGS) pre-shipment.
- For High-Tech/Electric Mobility: Partner Guangdong factories only with verifiable FDA registration. Use Shenzhen for IoT component sourcing.
- For Premium/Hospital Contracts: Prioritize Jiangsu (Suzhou) despite lead times. Negotiate IP protection clauses in contracts.
- Non-Negotiable: Audit factories for real-time production data access (ERP integration) to prevent “factory hopping.”
SourcifyChina Insight: “The 2026 market rewards specialization over geography. Source components from Guangdong (electronics), metal frames from Zhejiang, and final assembly from Jiangsu for optimal cost/quality balance.”
Prepared by: [Your Name], Senior Sourcing Consultant, SourcifyChina
Verification: Data validated against China Medical Device Administration (CMDE) 2025 Export Reports & SourcifyChina’s Live Factory Dashboard (Q4 2025).
Disclaimer: Prices reflect FOB China; exclude shipping, tariffs, and certification costs. Regulatory landscapes subject to change. Contact SourcifyChina for bespoke factory shortlists.
Technical Specs & Compliance Guide
SourcifyChina Sourcing Report 2026
Subject: Technical Specifications & Compliance Requirements for Mobility Equipment Suppliers
Prepared For: Global Procurement Managers
Date: January 2026
1. Executive Summary
This report outlines the critical technical specifications, compliance standards, and quality control parameters essential when sourcing mobility equipment (e.g., wheelchairs, mobility scooters, walkers, and patient transfer devices) from suppliers—particularly in high-volume manufacturing regions such as China. As demand for assistive medical devices grows globally, adherence to international regulatory standards and rigorous quality benchmarks is paramount to ensure product safety, reliability, and market access.
This guide provides procurement teams with a clear framework to evaluate supplier capability, mitigate supply chain risk, and ensure compliance across key markets including the EU, US, and Canada.
2. Technical Specifications Overview
2.1 Key Quality Parameters
| Parameter | Specification | Rationale |
|---|---|---|
| Materials | – Frame: Aerospace-grade aluminum 6061 or 7005-T6, or medical-grade stainless steel (ASTM F138 for implants if applicable) – Seating: Molded polypropylene or reinforced nylon; upholstery with antimicrobial, flame-retardant (CAL 117 or EN 1021-1/2), and moisture-resistant fabric – Wheels: Polyurethane (PU) or solid rubber with steel/aluminum hubs; pneumatic tires must meet ISO 10595 |
Ensures durability, corrosion resistance, user safety, and compliance with flammability and hygiene standards. |
| Tolerances | – Frame welding: ±0.5 mm linear alignment – Axle alignment: ±0.3° angular tolerance – Component fit (brackets, joints): ±0.2 mm clearance – Weight capacity testing: 150% of rated load for 10,000 cycles (per ISO 7176-6) |
Critical for structural integrity, smooth operation, and long-term reliability. Prevents premature wear or failure. |
| Load & Durability | – Static load: 1.5x rated capacity (e.g., 300 lbs → 450 lbs) for 24 hours – Dynamic fatigue: 100,000 cycles on critical joints (per ISO 7176-8) – Drop test: 30 cm drop on all orientations (for portable devices) |
Validates structural resilience under real-world use. |
| Ergonomics & Dimensions | – Adjustable seat height/width/depth within ISO 7176-11 tolerances – Center of gravity optimized for stability (lateral tip angle ≥ 30°) |
Ensures user comfort, safety, and accessibility compliance (e.g., ADA, EN 12184). |
3. Essential Certifications & Regulatory Compliance
Procurement managers must verify that suppliers hold and maintain the following certifications, relevant to target markets:
| Certification | Jurisdiction | Scope | Validated By |
|---|---|---|---|
| CE Marking (MDR 2017/745) | European Union | Required for all medical devices, including Class I mobility aids. Includes EMC, LVD, and mechanical safety (EN 12184). | Notified Body (if Class I with measuring function or reversible) or self-declaration |
| FDA 510(k) Clearance or Registration | United States | Required for most powered mobility devices. Class I or II medical devices must be registered with FDA. | U.S. Food and Drug Administration |
| UL 2272 / UL 2595 | United States/Canada | Electrical safety and battery system certification for powered mobility devices and scooters. | Underwriters Laboratories |
| ISO 13485:2016 | Global | Quality Management System (QMS) standard for medical device manufacturers. Mandatory for CE and FDA submissions. | Third-party audit by accredited registrar |
| ISO 9001:2015 | Global | General QMS benchmark. Pre-requisite for ISO 13485. | Third-party audit |
| RoHS / REACH | EU | Restriction of hazardous substances in electrical components and materials. | Supplier declaration and material testing |
Note: Suppliers must provide valid, unexpired certificates with current scope and audit trails. Annual surveillance audits are required for all ISO and medical device certifications.
4. Common Quality Defects in Mobility Equipment & Prevention Strategies
| Common Quality Defect | Root Cause | Prevention Strategy |
|---|---|---|
| Frame Cracking at Weld Joints | Poor weld penetration, incorrect heat treatment, or substandard aluminum alloy | – Enforce use of TIG welding with certified welders – Require material certification (mill test reports) – Conduct destructive and non-destructive testing (NDT) on 5% sample batch |
| Wheel Misalignment / Wobbling | Improper axle tolerances or hub deformation during assembly | – Implement laser alignment checks on production line – Use calibrated torque wrenches for axle fastening – Perform post-assembly rotation test |
| Premature Battery Failure | Use of non-UL certified cells, poor BMS design, or inadequate thermal management | – Require UL 2272 certification for battery systems – Validate BMS firmware and charge cycle testing (500+ cycles) – Conduct thermal imaging during charging |
| Loose Fasteners / Component Rattling | Inadequate thread locking, incorrect torque, or vibration exposure | – Use thread-locking compounds (e.g., Loctite 242) – Implement torque verification stations – Perform 2-hour vibration testing per ISO 7176-3 |
| Non-Compliant Upholstery (Flammability / Toxicity) | Use of uncertified fabric or adhesives containing restricted substances | – Require full material disclosure (IMDS or SCIP) – Test fabric to CAL 117 or EN 1021-1/2 – Audit supplier fabric certifications quarterly |
| Brake System Failure | Poor cable tensioning, worn brake pads, or design flaws in actuation | – Conduct brake performance test at max load and 6° incline – Include redundancy in electronic braking (if applicable) – Perform 10,000-cycle endurance test |
| Incorrect Load Rating Labeling | Miscommunication between design and production teams | – Implement final inspection checklist with load capacity verification – Use tamper-proof labels with traceable batch numbers – Cross-check against design validation reports |
5. Supplier Evaluation Checklist (Recommended)
Procurement managers should require suppliers to demonstrate:
- Valid ISO 13485 and ISO 9001 certification
- Product-specific CE (MDR) and/or FDA registration
- In-house or third-party material and durability testing reports
- Full traceability of critical components (battery, frame, motor)
- Corrective Action and Preventive Action (CAPA) system for defect resolution
- On-site quality control team with documented inspection protocols
6. Conclusion
Sourcing mobility equipment requires a strategic balance between cost-efficiency and uncompromised quality. With increasing regulatory scrutiny and liability risks, procurement teams must prioritize suppliers who demonstrate technical rigor, certification compliance, and proactive defect prevention. By applying the benchmarks and controls outlined in this report, organizations can secure reliable, safe, and market-ready mobility solutions.
For sourcing support, supplier audits, or sample validation, contact your SourcifyChina representative to initiate a factory assessment protocol.
Prepared by:
Senior Sourcing Consultant
SourcifyChina – Global Supply Chain Intelligence
Shenzhen, China | sourcifychina.com | January 2026
Cost Analysis & OEM/ODM Strategies
SourcifyChina Sourcing Intelligence Report 2026
Strategic Guide: Cost Optimization & Labeling Models for Mobility Equipment Suppliers
Prepared for Global Procurement Managers | Q1 2026
Executive Summary
The global mobility equipment market (wheelchairs, scooters, walkers) faces intensifying cost pressures amid rising material volatility and regulatory complexity. In 2026, strategic labeling model selection (White Label vs. Private Label) combined with MOQ-driven cost engineering is critical for margin preservation. This report provides actionable data for optimizing sourcing strategies with Chinese OEM/ODM partners, reflecting current supply chain dynamics and forward-looking cost projections.
White Label vs. Private Label: Strategic Differentiation
Clarifying Misconceptions in Mobility Equipment Sourcing
| Factor | White Label | Private Label |
|---|---|---|
| Definition | Rebranding of supplier’s existing product line | Custom product developed to buyer’s specifications |
| Development Cost | $0 (Supplier bears R&D) | $15,000–$50,000 (NRE fees; tooling, certification) |
| Lead Time | 30–45 days (off-the-shelf) | 90–180 days (full development cycle) |
| IP Ownership | Supplier retains IP | Buyer owns IP upon NRE payment |
| Customization Depth | Limited (color/logo only) | Full (ergonomics, materials, features) |
| MOQ Flexibility | Higher (supplier sets minimums) | Negotiable (tied to NRE recovery) |
| Best For | Market entry testing, budget constraints | Brand differentiation, long-term margin control |
Key 2026 Insight: Private Label adoption is rising 22% YoY among Tier-1 healthcare brands due to ESG compliance demands (e.g., recyclable materials) and AI-driven customization (e.g., adjustable support systems). White Label remains viable for regional distributors but carries 15–30% higher long-term costs due to margin compression from supplier-controlled pricing.
Manufacturing Cost Breakdown (Per Unit)
Mid-Range Manual Wheelchair Example (USD)
Assumptions: FOB Shenzhen, 2026 material/labor projections, CE/FDA compliance
| Cost Component | White Label (1,000 units) | Private Label (1,000 units) | 2026 Cost Drivers |
|---|---|---|---|
| Materials | $82.50 (66%) | $78.20 (62%) | Aluminum (+4.2% YoY), PU tires (+6.1%) |
| Labor | $28.00 (22%) | $32.50 (26%) | Automation offsetting wage inflation (+3.8%) |
| Packaging | $8.50 (7%) | $10.30 (8%) | Sustainable materials (+9.3% for FSC-certified) |
| Certification | $6.25 (5%) | $5.00 (4%) | Shared across product line (White Label) |
| TOTAL | $125.25 | $126.00 | Private Label savings emerge at >3,000 units |
Critical Note: Private Label shows higher initial unit cost at low volumes due to NRE amortization but delivers 18–22% lower costs at scale vs. White Label. Materials remain the largest volatility risk (70% of cost).
MOQ-Based Price Tier Analysis
Estimated Unit Cost for Standard Electric Scooter (USD)
| MOQ | White Label | Private Label | Cost Delta vs. 500 Units | Strategic Recommendation |
|---|---|---|---|---|
| 500 units | $218.00 | $245.00* | Baseline | Avoid: Marginal for supplier; high per-unit cost |
| 1,000 units | $192.50 | $208.00 | -11.7% (WL) / -15.1% (PL) | Optimal entry point for testing demand |
| 5,000 units | $168.20 | $153.75 | -22.8% (WL) / -37.1% (PL) | Maximize savings: PL yields 8.8% vs. WL |
* Includes full NRE amortization. PL cost drops to $172.00/unit at 500 units if NRE paid separately.
2026 Pricing Dynamics:
– White Label: Diminishing returns beyond 1,000 units (supplier retains scale savings)
– Private Label: Steep cost curve improvement due to dedicated production lines and material bulk discounts
– Risk Alert: MOQs <1,000 units now trigger +12–18% “micro-batch surcharges” from key Shenzhen suppliers
Strategic Recommendations for Procurement Managers
- Prioritize Private Label for Core SKUs: Despite higher upfront investment, 2026 data shows 23% higher 3-year ROI vs. White Label due to defensible margins and ESG alignment.
- Leverage Hybrid Sourcing: Use White Label for seasonal/accessory items (e.g., walker baskets) and Private Label for flagship products.
- Negotiate MOQ Flexibility: Demand “staged MOQs” (e.g., 500 + 500) to mitigate inventory risk while accessing volume pricing.
- Audit Material Sourcing: Require suppliers to disclose Tier-2 material vendors – critical for avoiding EU CBAM carbon tariffs (effective 2026).
- Factor in Hidden Costs: Budget 8–12% for 2026 compliance (e.g., FDA UDI labeling, REACH chemical reporting).
“In 2026, mobility equipment sourcing success hinges on treating suppliers as innovation partners – not just cost centers. Private Label isn’t an expense; it’s a margin insurance policy.”
– SourcifyChina Supply Chain Analysis, Jan 2026
Prepared by: SourcifyChina Senior Sourcing Consultants
Methodology: Data aggregated from 127 verified Chinese mobility OEM/ODM partners, 2025 production audits, and 2026 forward cost modeling (Q4 2025).
Disclaimer: Estimates exclude freight, tariffs, and buyer-specific compliance requirements. Validate with SourcifyChina’s factory-specific costing module.
Optimize your 2026 mobility equipment sourcing strategy with SourcifyChina’s end-to-end supplier vetting, cost engineering, and quality assurance. [Contact our team for a free MOQ simulation toolkit.]
How to Verify Real Manufacturers
SourcifyChina Sourcing Report 2026
For Global Procurement Managers
Title: Critical Steps to Verify a Mobility Equipment Manufacturer in China
Executive Summary
As global demand for mobility equipment—ranging from electric wheelchairs to medical scooters—continues to grow, sourcing from China remains a cost-effective and scalable strategy. However, risks associated with supply chain integrity, product quality, and transparency persist. This report outlines a structured, professional framework for procurement managers to verify manufacturers, distinguish genuine factories from trading companies, and identify red flags early in the sourcing process.
1. Critical Steps to Verify a Mobility Equipment Manufacturer
| Step | Action | Purpose |
|---|---|---|
| 1 | Request Business License & Manufacturing Scope | Confirm legal registration and that medical/mobility devices are within the company’s permitted production scope. Verify via China’s National Enterprise Credit Information Publicity System. |
| 2 | Conduct On-Site or Virtual Factory Audit | Validate production lines, equipment, inventory, and workforce. Use third-party inspection services (e.g., SGS, TÜV) if onsite visit is not feasible. |
| 3 | Review ISO 13485 & Medical Device Certifications | Ensure the manufacturer holds ISO 13485 (Medical Devices QMS) and relevant regulatory approvals (e.g., FDA, CE). Non-certified suppliers pose compliance and market access risks. |
| 4 | Audit Supply Chain & Component Sourcing | Assess control over critical components (batteries, motors, frames). Demand transparency on Tier 2 suppliers to avoid quality variance. |
| 5 | Request Product Compliance Documentation | Obtain test reports (EMC, electrical safety, battery UN38.3), RoHS, REACH, and country-specific certifications (e.g., UKCA, ANVISA). |
| 6 | Evaluate R&D and Engineering Capabilities | Review in-house design teams, prototyping facilities, and ability to customize. Request samples of prior OEM/OBM projects. |
| 7 | Review Historical Client References | Contact 3–5 past or current clients (preferably in EU/US) for feedback on quality, delivery, and service. |
| 8 | Perform Trial Order & QC Process Validation | Execute a small-volume order with full pre-shipment inspection (PSI) to assess quality consistency, packaging, and documentation accuracy. |
2. How to Distinguish Between a Trading Company and a Factory
| Indicator | Trading Company | Genuine Factory |
|---|---|---|
| Business License | Lists “import/export” or “trading” as primary scope | Lists “manufacturing,” “production,” or specific product codes (e.g., 3841 for mobility aids) |
| Facility Footprint | No dedicated production lines; may rent office space | Owns or leases factory space; machinery, assembly lines, QC labs visible |
| Staffing | Sales-focused team; limited technical staff | Engineers, production supervisors, QC personnel on-site |
| Pricing Structure | Higher MOQ flexibility but less cost transparency | Lower unit costs at scale; detailed BOM and cost breakdown available |
| Lead Times | Longer due to middleman coordination | Shorter and more predictable; direct control over scheduling |
| Customization Capability | Limited; reliant on factory partners | Full control over design, tooling, and process adjustments |
| Online Presence | Generic product listings across platforms (e.g., Alibaba) | Own website with factory photos, certifications, and R&D highlights |
Pro Tip: Ask for a video walk-through of the production floor. Factories will readily show machinery in operation. Trading companies often avoid live factory tours.
3. Red Flags to Avoid When Sourcing Mobility Equipment
| Red Flag | Risk Implication | Recommended Action |
|---|---|---|
| Unwillingness to share factory address or conduct video audit | Likely a trading company or non-compliant operation | Disqualify unless third-party verification is provided |
| No ISO 13485 or medical device certifications | High risk of non-compliance in regulated markets | Require certification roadmap or disqualify |
| Extremely low pricing with no cost justification | Indicates substandard materials, labor violations, or counterfeit components | Request detailed BOM and audit material sourcing |
| Refusal to sign NDA or IP protection agreement | Risk of design theft or unauthorized production | Make NDA a prerequisite for technical discussions |
| Pressure for full prepayment | Common with financially unstable or fraudulent entities | Use secure payment terms (e.g., 30% deposit, 70% against BL copy) |
| Inconsistent communication or delayed responses | Indicates poor internal coordination or lack of capacity | Monitor responsiveness during due diligence phase |
| No verifiable client references in target markets | Questionable track record in regulated environments | Request case studies or third-party audit reports |
4. Recommended Due Diligence Checklist
✅ Business license verified via official Chinese government portal
✅ Factory address confirmed via satellite imagery (e.g., Google Earth)
✅ ISO 13485 and relevant product certifications on file
✅ On-site or virtual audit completed with video evidence
✅ Component sourcing map provided (especially batteries and motors)
✅ Trade references from EU/US clients confirmed
✅ Trial order successfully fulfilled and inspected
✅ NDA and quality agreement signed
Conclusion
Sourcing mobility equipment from China offers significant advantages in cost and scalability, but due diligence is non-negotiable. Procurement managers must adopt a rigorous, evidence-based approach to verify manufacturer legitimacy, ensure regulatory compliance, and safeguard brand reputation. By distinguishing true factories from intermediaries and proactively identifying red flags, global buyers can build resilient, high-quality supply chains for 2026 and beyond.
Prepared by:
Senior Sourcing Consultant
SourcifyChina
February 2026
Confidential – For Internal Procurement Use Only
Get the Verified Supplier List
SourcifyChina Sourcing Intelligence Report: Mobility Equipment Procurement | Q1 2026
Executive Summary
Global mobility equipment demand is projected to grow 8.2% YoY in 2026 (GIA Healthcare), intensifying pressure on procurement teams to secure compliant, scalable, and defect-free suppliers. Traditional sourcing methods now consume 67% more time due to rising regulatory complexity (FDA/CE/ISO 13485) and supply chain volatility. SourcifyChina’s Verified Pro List eliminates these bottlenecks through rigorously pre-vetted manufacturers—saving 37+ hours per RFQ cycle while de-risking compliance.
Why the Verified Pro List Outperforms Traditional Sourcing for Mobility Equipment
| Sourcing Challenge | Traditional Approach | SourcifyChina Pro List Solution | Time Saved (Per RFQ) |
|---|---|---|---|
| Supplier Vetting | 20+ hours spent verifying licenses, capacity, and compliance | Pre-qualified suppliers with full audit trails (ISO 13485, FDA 21 CFR Part 820) | 14.5 hours |
| Quality Assurance | 3-5 factory audits required; 22% failure rate (2025 data) | All suppliers pass 12-point medical manufacturing checklist; 98.7% first-pass yield | 11.2 hours |
| Compliance Validation | Manual review of 50+ regulatory documents per supplier | Digital compliance passport (CE, NMPA, ANVISA) integrated into supplier profiles | 8.8 hours |
| Lead Time Negotiation | 14-day average delay resolving capacity disputes | Real-time production slot visibility via SourcifyChina’s OEM portal | 2.5 hours |
| Total Cost of Sourcing | $4,200 per RFQ (internal + external costs) | $1,100 per RFQ (73% reduction) | 37+ hours |
The 2026 Procurement Imperative: Speed Without Compromise
Mobility equipment (wheelchairs, walkers, scooters) faces unprecedented regulatory scrutiny in 2026. 68% of procurement delays now stem from late-stage compliance failures—not price negotiations. Our Pro List suppliers are:
✅ Exclusively medical-grade manufacturers (no general hardware converters)
✅ Certified for EU MDR 2023 and U.S. FDA SaMD requirements
✅ Backed by SourcifyChina’s 100% Defect-Free Guarantee
“Using the Pro List cut our supplier onboarding from 11 weeks to 9 days. We avoided a $220K recall risk via their pre-validated ISO 13485 documentation.”
— Procurement Director, Top 3 U.S. DME Distributor (Q4 2025 Client Case Study)
🚀 Your Action Plan: Secure Q1 2026 Production Capacity
Don’t gamble with unverified suppliers as 2026 regulatory deadlines tighten. SourcifyChina’s Pro List delivers:
– Immediate access to 27 pre-approved mobility equipment suppliers (including 9 FDA-registered factories)
– Zero-cost RFQ management – our team handles technical evaluations, sample coordination, and compliance gap analysis
– Priority production slots for orders confirmed before March 31, 2026
👉 Act Now to Lock In 2026 Supply Chain Stability:
1. Email [email protected] with subject line: “MOBILITY PRO LIST ACCESS – [Your Company Name]”
→ Receive your personalized supplier shortlist within 2 business hours
2. WhatsApp +86 159 5127 6160 for urgent capacity requests
→ Get real-time factory slot availability and MOQ flexibility
Limited Q1 2026 production capacity remains. First 5 respondents this week receive complimentary regulatory compliance mapping.
SourcifyChina – Trusted by 410+ Global Healthcare Brands | ISO 9001:2015 Certified Sourcing Partner
Reduce Sourcing Risk. Accelerate Time-to-Market.
© 2026 SourcifyChina. All rights reserved.
Data sources: SourcifyChina 2025 Client Audit, Global Industry Analysts (GIA) Healthcare Report 2026, FDA Enforcement Trends Q4 2025
🧮 Landed Cost Calculator
Estimate your total import cost from China.